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Abstract
Background—The role of Endoplasmic Reticulum (ER) stress response in mental illness is not
well understood. Human studies and animal models of depression show elevated brain ER stress
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response. In addition, some ER stress associated disorders (e.g. cardiovascular disease) show
higher rates of depression compared to the general population, raising the possibility that ER stress
response contributes to depression risk. It remains unknown, however, if ER stress response is
present among individuals suffering from other stress-related mental illness, and whether such a
response would be evident in a non-clinical sample. This study tests for systemic changes in ER
stress response associated with major depressive disorder (MDD) or post-traumatic stress disorder
(PTSD) among community-dwelling individuals.
Methods—We analyzed expression of BiP, EDEM1, CHOP, and XBP1, the major indicators of
ER stress response, with Real-Time PCR in leukocyte-derived RNA samples from 86 participants
of the Detroit Neighborhood Health Study. Participants were selected based on the presence of
either past year MDD or past year PTSD; controls were age and sex matched.
Results—Relative to controls, MDD is associated with a 1.34-fold increase in BiP (P=0.004),
1.35-fold increase in EDEM1 (P=0.001), 1.68-fold increase in CHOP (P=0.002), and 1.60-fold
increase in XBP1 (P=0.004). These results remained significant after correction for multiple
testing. In contrast, PTSD is associated with a 1.27 fold increase in EDEM1 expression only
(P=0.027), a result that is attenuated to non-significance following adjustment for multiple testing;
however, a subsample of participants with past month PTSD showed elevated expression of BiP
and EDEM1 (uncorrected p value 0.049 and 0.017, respectively).
Conclusions—These data indicate systemic and persistent activation of the ER stress response
pathway in MDD among community-dwelling individuals. Systemic activation of the ER stress
response may also occur in PTSD among persons with more recent symptoms.
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Introduction
Several human studies and animal models suggested that endoplasmic reticulum (ER) stress
response may play a role in psychiatric disease (Bown et al., 2000; Gold et al., 2013). The
ER is an intracellular organelle that is responsible for protein folding and assembly, calcium
storage, and lipid and sterol biosynthesis (Back et al., 2005). A variety of pharmacological,
pathophysiological, and environmental stimuli can impose stress on the ER and
subsequently interrupt the protein folding process in the ER, leading to accumulation of
unfolded or misfolded proteins in the ER lumen (Zhang and Kaufman, 2004). This condition
is referred to as “ER stress” (Zhang and Kaufman, 2004). To cope with ER stress, highly
specific signaling pathways localized to the ER have evolved, which are collectively called
the ER stress response or the “Unfolded Protein Response (UPR)”. The primary function of
the UPR is to restore ER homeostasis and help the cells adapt to ER stress conditions.
However, when ER stress is prolonged or the degree of ER stress is too severe, UPR
signaling can initiate programmed cell death by activating stress-induced pro-apoptotic
factors (Zhang and Kaufman, 2004). Dysregulation or hyper-activation of the UPR pathway
is critically involved in the initiation and progression of a variety of life-threatening
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diseases, such as cardiovascular disease, metabolic disease, neurodegenerative disease, and
cancer (Zhang and Kaufman, 2008).
ER stress related protein expression has been shown to be elevated within the temporal
cortex among individuals who had Major Depressive Disorder (MDD) and died of suicide
compared with individuals who had MDD and died of other causes (Bown et al., 2000). A
recent paper suggests that ER stress and parainflammation–i.e. a tissues’ stress response
with features intermediate between a normal state and an acute inflammatory state–are
interrelated processes each influencing many phases of the stress response pathway and as
such these pathways may be valid targets for intervention in MDD and bipolar disorder
(Gold et al., 2013). Some pharmacological interventions used to treat affective disorders
target genes which interact with the UPR pathways (e.g. Wang et al., 1999). For example,
valproate and carbamazepine are mood stabilizing drugs which increase expression of 78-
kilodalton glucose-regulated protein (GRP78), also known as Binding immunoglobulin
protein (BiP) (Wang et al., 1999). BiP/GRP78 is a member of the ER stress gene family
believed to inhibit ER stress response activation and to inhibit UPR induced apoptosis
(Reddy et al., 2003). Furthermore, lithium is a treatment employed for some mood disorders
and is known to directly target and inhibit the protein encoded by Glycogen synthase
kinase-3 (GSK3); GSK3 has been shown to regulate ER stress induced apoptosis in neuronal
cells (Meares et al., 2011). Several mouse models of depression-like behavior implicate
genes which interact with the UPR pathways, e.g. Calreticulin (CALR)(Liu et al., 2011), Bax
inhibitor 1(BAX)(Hunsberger et al., 2011), Glycogen synthase kinase-3 (GSK3B)(Mines et
al., 2010; Meares et al., 2011), Interferon-gamma (IFNG)(O’Connor et al., 2009), and
Tumor necrosis factor-α(TNF) (Kaster et al., 2012). These human studies and animal
models suggest that the UPR pathways may be activated or up regulated within brain tissue
in the presence of some affective disorders.
Despite the suggestive evidence of ER stress in mental disorders in both animal (Hunsberger
et al., 2011; Liu et al., 2011)) and human (Bown et al., 2000; So et al., 2007) studies, to date
there has to our knowledge been no report of ER stress and the UPR among living
individuals suffering from such disorders. More specifically, it is not known whether the ER
stress response pathway is activated at a systemic level among community-dwelling
individuals suffering from MDD. Here we test whether ER stress-related gene expression is
elevated in leukocytes derived from individuals diagnosed with MDD in the Detroit
Neighborhood Health Study (DNHS). The DNHS is a longitudinal community-based study
of mental and physical health and their interaction with social-environmental factors (Uddin
et al., 2010, Goldmann et al., 2011). Elevated ER stress response may be specific to MDD
or it may be associated with additional mental disorders in which stress plays a contributing
role. To test this, we also investigated whether ER stress response-related gene expression is
elevated in leukocytes derived from individuals diagnosed with post-traumatic stress
disorder (PTSD) in the Detroit Neighborhood Health Study (DNHS). To our knowledge this
is the first consideration of whether PTSD is associated with elevated ER stress response
and is facilitated by the relatively high burden PTSD in the DNHS population (Uddin et al.,
2010). Results from this work may provide insight into biological processes relevant to
psychological stress that occur in non-clinical settings.
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Details of the Detroit Neighborhood Health Study (DNHS) have been previously reported
(Uddin et al., 2010, Goldmann et al., 2011, Uddin et al., 2011). The University of Michigan
IRB reviewed and approved this study. Our study sample consisted of a subset of the DNHS
study participants with previously extracted RNA from leukocytes (described in more detail
below). We employed a matched pair study design based on past year MDD cases (n=18)
and their age- and gender-matched controls (n=18) and past year PTSD cases (n=26) and
their age and gender-matched, trauma-exposed controls (n=26). Note that two participants
serve the role of matched control in both the MDD and PTSD control samples (total sample
n=86).
Assessment of PTSD and MDD
Past year MDD was assessed by a structured telephone interview using validated
instruments based on DSM-IV criteria (APA, 1994). The Patient Health Questionnaire
(PHQ-9)(Kroenke et al., 2001) was used to assess depression symptoms. The nine items on
the PHQ-9 were scored from 0 (not at all) to 3 (nearly every day), with scores ranging from
0 to 27. In our MDD positive cases, the respondent experienced at least 5 symptoms more
than half the time; this corresponds with a score of 10 out of 27 possible. Additional
questions were added to these measures to determine the timing, duration and severity of
illness and also symptom-related disability. We selected participants diagnosed with MDD
during their lifetime who have also experienced symptoms during the past year. We selected
age and sex matched control cases who have no lifetime history of MDD. We further
excluded participants who have a lifetime history of PTSD as described below.
Past year PTSD was assessed in the following manner: Participants were asked to identify
potentially traumatic events (PTEs) from a list of 19 categories of events. PTSD symptoms
were assessed in reference to both the traumatic event the participant regards as their worst
and one randomly selected traumatic event from the remaining traumas the participant has
experienced. Lifetime PTSD cases met all six DSM-IV criteria in reference to either the
worst or random traumatic event. After determining that a participant had a lifetime history
of PTSD, we asked a follow up question regarding the length of time since an individual
experienced any symptoms. We included only those individuals who have also experienced
PTSD symptoms within the past year. We excluded participants with a history of lifetime
MDD as described above. Finally, we identified a subset of these past year PTSD cases (and
matched controls) who have experienced PTSD symptoms within the past month (n=32).
PTSD and depression diagnoses have been validated in a random subsample of participants
via in-person clinical interview using the clinician-administered PTSD scale for DSM-IV
and the structured clinical interview for DSM-IV disorders, respectively, as previously
described (Uddin et al, 2010).
Expression levels of ER stress related genes
Eighteen ml of whole blood was collected from consenting DNHS participants. Total
leukocyte RNA was isolated using the LeukoLOCK Fractionation and Stabilization kit
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(Ambion) using the manufacturer’s alternative protocol. Quantitative reverse-transcriptase
real time PCR (qRT-PCR) was used to quantify mRNA expression of ER stress-related
genes (Zhang and Kaufman, 2004). These genes included: 1) BiP/GRP78, an abundant ER
chaperone protein which has been recognized as a reliable ER stress marker and a master
regulator of the UPR pathways (Zhang and Kaufman, 2004); 2) the growth arrest and DNA
damage-inducible protein GADD34/CHOP, an ER stress-induced pro-apoptotic factor under
the UPR pathway mediated through PERK/eIF2α (Zhang and Kaufman, 2004). Induction of
CHOP can represent induction of the PERK/eIF2α UPR pathways and ER stress-induced
apoptosis (Zhang and Kaufman, 2004); 3) ER degradation enhancer, Mannosidase alpha-like
1 (EDEM1), an ER stress-inducible factor that is involved in ER-associated degradation
(ERAD) of misfolded proteins (Molinari et al., 2003); and 4) The spliced form of X-box
binding protein 1 (XBP1), an ER stress-induced bZIP transcription factor that is under the
IRE1α-mediated UPR pathways. Induction of the spliced XBP1 mRNA (XBP1s) is an
indication of activation of the IRE1α/XBP1 UPR pathway.
First strand cDNA was synthesized from 500ng of total RNA using the SuperScript III First-












Note that the sense primer for XBP1 includes 4 bp before and 12 bp after a 26 bp region
which is removed from exon 4 through non-conventional splicing during XBP1 activation.
Therefore this primer pair is expected to anneal only the spliced form of the gene; a similar
strategy has been employed to investigate the function of the spliced form of XBP1in the
literature (Back, et al., 2005; Hirota, et al., 2006). The real-time PCR reaction mixture (10μl)
containing 125nM primers, cDNA template and SYBR Green PCR Master Mix (Invitrogen
# 4385612) was amplified in a 7500 Fast Real-time PCR System (Applied Biosystems).
Cycling conditions included: holding stage at 95°C for 20 seconds; 40 cycling stages at
95°C for 3 seconds, 60°C for 30 seconds. Negative reverse transcriptase samples were used
to ensure the absence of contaminating genomic DNA. All reactions were performed in
triplicate. Each set of triplicates was checked to ensure that the threshold cycle (Ct) values
are all within 1Ct of each other. Fold changes were determined after normalizing to beta-
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actin as the internal control. The 2−ΔCt method (Livak and Schmittgen, 2001, Schmittgen
and Livak, 2008) was employed to determine the relative expression values of the cases
compared with age and sex matched controls. Normality was tested using a Shapiro-Wilk
test. We tested for significant differences between case and control in the 2−ΔCt values using
the non-parametric paired sample Wilcoxon signed rank test (P≤0.05) or the parametric
paired samples T test, as appropriate. We tested which genes show a significant difference
between cases and controls when a Bonferroni correction for multiple comparisons is
employed (P≤0.0125).
Prevalence of cardiovascular disease associated with ER stress in cases vs. controls
Recent work has demonstrated that ER stress, and the consequent induction of the UPR
plays a major role in the pathophysiology of cardiovascular (CVD)-related disorders such as
cardiac hypertrophy, heart failure, atherosclerosis, and ischemic heart disease (Minamino
and Kitakaze, 2010; Jiao et al., 2012). Therefore, as a secondary analysis, we tested whether
there was a significant difference between cases and controls with respect to the prevalence
of CVD. The prevalence of CVD was determined by assessing the presence/absence of
conditions previously identified as indicative of CVD in the DNHS cohort (Keyes et al.,
2013) and which have been previously associated with the ER stress response, including:
hypertension (i.e. high blood pressure) (Sun et al., 2008), myocardial infarction (i.e. heart
attack) (Thuerauf et al., 2006), stroke (Chae et al., 2004), chest pain due to heart disease
(angina pectoris)(Myoishi et al., 2007), and congestive heart failure or heart disease
(Hamada et al., 2004). Presence/absence of these diseases was assessed with a structured
phone interview survey in which respondents were asked to respond “Has a doctor ever told
you that you have [ITEM]?”, with [item] referring to the four CVD-related conditions listed
above. Cases meeting at least one of these criteria were identified as positive for CVD.
Differences in the prevalence of CVD were tested using a McNemar’s test (P≤0.05), a
paired version of the Chi-square test.
Results
Table 1 describes the demographic profile of the study participants. A Chi squared test
shows no difference between case and control groups with respect to age, sex, or race/
ethnicity.
Past year MDD is associated with induction of the ER stress response and activation of
multiple UPR pathways in leukocyte samples (Figure 1)
Among past year MDD cases, there is a 1.34 fold increase in expression of the ER
chaperone BiP (P=0.004; mean ± s.d. 2−ΔCT for cases 0.0025 ± 0.0014 and controls 0.0019
± 0.0009). The ERAD mediator EDEM1 also shows a 1.35 fold increase (P=0.001; mean ±
s.d. 2−ΔCT for cases 0.0125 ± 0.0036 and controls 0.0092 ± 0.0026) among MDD cases. In
addition, there is a 1.68 fold increase in the expression of the ER stress-induced pro-
apoptotic factor CHOP (P=0.002; mean ± s.d. 2−ΔCT for cases 0.0011 ± 0.0007 and controls
0.0006 ± 0.0005). Finally, MDD cases show a 1.60 fold increase in expression of the spliced
(i.e. activated) form of the UPR trans-activator XBP1 (P=0.004; mean ± s.d. 2−ΔCT for cases
0.0327 ± 0.0366 and controls 0.0205 ± 0.0245). Each of these genes remains significantly
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differently expressed between cases and controls when adjusted for multiple comparisons
using the stringent Bonferroni correction (P≤0.0125). Because our study sample included
only 10 individuals with past month MDD, we did not assess ER stress activation for this
phenotype.
Past year PTSD is associated with elevated expression of genes involved in ER-associated
degradation (ERAD) of misfolded proteins in leukocyte samples (Figure 1)
Among past year PTSD cases, EDEM1 shows a 1.27 fold increase (P=0.027; mean ± s.d.
2−ΔCT for cases 0.0054 ± 0.0039 and controls 0.0036 ± 0.0020) in expression compared to
controls. Expression of BiP also shows a 1.16 fold increase in cases that approaches
significance (P=0.069; mean ± s.d. 2−ΔCT for cases 0.0048 ± 0.0034 and controls 0.0042 ±
0.0028). In contrast to MDD cases, past year PTSD cases do not show a statistically
significant increase in the expression of CHOP or XBP1 in cases compared with controls
(P>0.05). When a conservative adjustment is made to account for multiple comparisons, i.e.
the Bonferroni correction, EDEM1 expression is no longer significantly different between
cases and controls.
Time since participant experienced PTSD symptoms does not alter the expression pattern
of the ER stress-related genes (Figure 1)
The expression levels of BiP and EDEM1 are elevated in past month PTSD cases; similarly,
BiP and EDEM1 expression levels are elevated in past year PTSD. Among PTSD cases who
experienced symptoms recently (within the past month), there is a 1.25 fold increase in BiP
expression (P=0.049; mean ± s.d. 2−ΔCT for cases 0.0036 ± 0.0020 and controls 0.0029 ±
0.0017), and EDEM1 also shows a 1.55 fold increase (P=0.017; mean ± s.d. 2−ΔCT for cases
0.0054 ± 0.0050 and controls 0.0034 ± 0.0028). The expression levels of CHOP and XBP1
are not significantly different in cases compared with controls among either past month or
past year PTSD cases. When a conservative adjustment is made to account for multiple
comparisons, i.e. the Bonferroni correction, BiP and EDEM1 expression is no longer
significantly differently expressed between cases and controls.
Prevalence of cardiovascular disease in case and control groups
The ER stress response is associated with CVD (Glembotski, 2007). Moreover, PTSD plays
a role in increased risk and severity of cardiovascular disease (Kubzansky et al., 2007;
Boscarino and Adams, 2008;,). Similarly, depression is a well-recognized risk factor for
coronary artery disease (Grippo and Johnson, 2002). Consequently, we hypothesized a role
for ER stress response in the comorbidity between mental disease and CVD and tested
whether there were differences in the prevalence of this disorder among particpants with vs.
without MDD or PTSD. No significant differences are found between our case and control
groups according to a McNemar’s Chi-squared test P>0.05 [Table 2]. These data suggest
that the differences shown in expression levels between cases and controls are likely due to
psychological disease independent of CVD disease.
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Here we report that community-dwelling individuals with a recent history of stress-related
mental disorders show activation of the ER stress response and an increase in UPR related
gene expression in peripheral leukocytes. The pattern of activation of the UPR pathways
differed to some degree between MDD and PTSD, with MDD cases showing evidence of
more pronounced ER stress response. In addition, the pattern of ER stress response was
generally consistent in cases experiencing PTSD symptoms in the past month and the past
year, indicating a persistent activation of the ERAD-associated UPR pathway among those
suffering from this disorder. Secondary analyses of the prevalence of ER-stress associated
CVD showed no difference between MDD- and PTSD- cases and their respective controls;
consequently, differences observed between cases and controls are likely to be due
specifically to the mental illness. Taken together, these results suggest that stress-related
mental disorders, in particular MDD, are associated with a systemic, persistent ER stress
response and activation of the UPR pathways.
The expression profiles observed in these data suggest both commonalities and
dissimilarities in the pattern of ER stress response associated with MDD or PTSD. The ER
stress marker BiP is up-regulated in both MDD and in past month PTSD. BiP is
transcriptionally activated by several mediators of the UPR, and the high expression level in
MDD and past month PTSD indicate an elevation in the level of systemic ER stress.
Increased expression of BiP suggests induction of ER stress response and activation of the
UPR pathways (Bertolotti et al., 2000, Gulow et al., 2002). EDEM1 directly regulates ER-
associated degradation (ERAD) by targeting misfolded glycoproteins for degradation in an
N-glycan-independent manner (Ron et al., 2011). Elevated expression of EDEM1 indicates
induction of ER stress response and activation of the UPR that facilitates degradation of
misfolded proteins in the ER (Molinari et al., 2003). In both MDD and PTSD, we found
EDEM1 expression is elevated.
In contrast, in MDD--but not PTSD--CHOP and XBP1 expression are elevated. CHOP
expression is one downstream indicator of the PERK-mediated UPR pathway (Zhang and
Kaufman, 2004). Additionally, CHOP is also recognized as a pro-apoptotic factor in ER
stress-induced apoptosis (Zhang and Kaufman, 2004). Up-regulation of CHOP in MDD but
not PTSD cases suggests that the PERK-mediated UPR pathway and ER stress-induced
apoptosis in MDD may be more prevalent than that in PTSD. Finally, XBP1 is a
transcription factor that positively regulates BiP, EDEM1, CHOP, and itself when the UPR
is activated (Figure 2: adapted from Takayanagi et al., 2013). Notably, activation of XBP1 is
mediated through IRE1α, the proximal UPR transducer (Zhang and Kaufman, 2004). Under
ER stress conditions, IRE1α is activated to function as an RNase in order to alternately
splice XBP1 mRNA. Spliced XBP1 mRNA encodes a functional transcription factor that
activates expression of the UPR target genes. Changes in the expression level of spliced
XBP1 can therefore reflect ER stress response and activation of the IRE1α-mediated UPR
pathway, which regulate ERAD and expression of BiP. The elevated XBP1 expression level
in MDD may indicate a change in ER homeostasis and activation of the IREα-mediated
UPR pathway.
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ER stress may provide a mechanistic link between physical and mental diseases. Activation
of ER stress and UPR related gene expression in MDD and PTSD may contribute to
increased risk of a variety of physical diseases. Elevated ER stress genes in vascular tissue
correlate with accelerated atherosclerotic plaque development in APOE deficient mice
(Khan et al., 2009). Atherosclerosis results from a passive buildup of cholesterol in the
artery wall (Libby et al., 2013). Diabetes increases atherosclerosis-related inflammation, and
diabetic patients are twice as likely to have a heart attack or stroke. Khan and colleagues
show that hyperglycemia-induced vascular ER stress response plays a role in diabetic
atherosclerosis, and that inhibition of ER stress response attenuates diabetic atherosclerosis
(Khan et al., 2009). There are significant comorbidities between diabetes and stress-related
mental disorders such as MDD and PTSD (Anderson et al., 2001; Simon et al., 2006). It is
plausible that increased expression levels of ER stress related genes in the peripheral blood
in MDD may accelerate or facilitate atherosclerotic plaque development. Moreover, elevated
ER stress may play a role in the risk of developing comorbid psychological and
cardiovascular disease.
We recently showed that DNHS participants with lifetime depression showed evidence of
increased inflammation (Uddin et al., 2010). In addition, we (Uddin et al., 2011) and others
(Smith et al., 2011) have reported that participants with lifetime PTSD show epigenetic
dysregulation in multiple immune-related genes, and an exaggerated immune response to a
common pathogen (Uddin et al., 2010). General inflammation, oxidative stress, and calcium
homeostasis share bi-directional interactions with the UPR pathway (Zhang, 2010). There
are multiple lines of evidence suggesting that in addition to its roles in the ER stress
response, the protein encoded by XBP1 plays key roles in moderating innate immune
response to pathogens. In the absence of XBP1 expression, pathogen induced inflammation
results in an exaggerated ER stress response (Richardson et al., 2010). In the absence of
XBP1 expression, researchers report increased inflammation in the intestinal epithelium
(Kaser et al., 2008). Conversely, XBP1 expression protects the host against ER stress caused
by its own secretory immune response to infection (Richardson et al., 2010). Elevated rates
of inflammation are a common phenotype associated with mental disorders including MDD
and PTSD (Dantzer et al., 2008; Plantinga et al., 2013). It is possible that high expression
levels of XBP1 in MDD cases may represent an adaptive response to elevated levels of
inflammation associated with MDD. Unfortunately, up-regulation of XBP1 also modulates
lipid and glucose metabolism, which is associated with cardiovascular and metabolic
diseases (Glimcher and Lee, 2009; Lee et al., 2012). Consequently, elevated ER stress
conditions and activated XBP1 expression may also play a role in the risk of developing
comorbid psychological, cardiovascular and metabolic disease.
A non-invasive, quantitative clinical test of a single biomarker to aid in the diagnosis and
treatment of MDD remains elusive (Lakhan et al, 2010). A variety of peripheral/serum
growth factors, cytokines, hormones, and metabolic factors have been shown to be altered in
MDD but are not specific to MDD, e.g. BDNF, IL-6, and TNF-a; a multivariate biomarker
panel may in combination improve sensitivity and specificity for diagnosis and treatment of
MDD (Schmidt, et al., 2011). Our data preliminarily suggest that ER stress pathway
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activation may represent an additional set of biomarkers that may contribute to diagnosis of
MDD.
STUDY LIMITATIONS
Our study includes a minimum of four limitations that should be considered. First, the cross-
sectional analyses reported here leave us unable to determine whether the differences in
expression were a consequence of MDD or PTSD or whether the differences in expression
are indicative of biologic vulnerabilities that existed among the MDD-affected or PTSD-
affected individuals before the onset of their disorder. Ongoing work using samples from
this same longitudinal cohort may be informative regarding this distinction. Second, our
focus on peripheral tissues limits the inferences that can be drawn about ER stress in the
brain. Third, our sample size (n = 86) is modest. Nonetheless, we did observe statistically
significant changes in expression (P≤0.05) across several members of the ER stress
pathway, suggesting that the findings reported here are robust. Moreover, we applied an
extremely stringent method to adjust for repeated measures which increases the probability
of falsely rejecting a hypothesis, yet the expression data for MDD remained significantly
different between cases and controls in each of the ER stress response genes that we tested.
Finally, we assessed presence/absence of CVD-related conditions through self-report of a
doctor’s diagnosis. This may underreport CVD in our control sample. Given these results,
replicating this work in independent cohorts is warranted.
Conclusion
Two stress-related mental disorders--MDD and PTSD--correlate with elevated expression
levels of genes involved in the ER stress pathway. To our knowledge this is the first report
associating PTSD or MDD with high systemic levels of ER stress. Patients diagnosed with
either MDD or PTSD have an elevated risk of a variety of physical diseases. The ER stress
response may contribute to this association, particularly with respect to heart disease and
diabetes.
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Average fold change between cases and controls for Major Depressive Disorder and Post
Traumatic Stress Disorder.
The closed circle indicates a statistically significant increase in expression in cases
compared with controls at (uncorrected p<0.05). The star symbol indicates a statistically
significant increase in expression in cases compared with controls at (P<0.0125; i.e. a≤0.05
adjusted for multiple comparisons with the Bonferroni correction). ER stress related gene
expression is elevated in MDD and PTSD.
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ER stress transcriptional network and dysregulation in Major Depressive Disorder and Past
Month Post Traumatic Stress Disorder.
Each grey arrow indicates a transcriptional target of a significantly up regulated gene. Each
white arrow indicates aspects of the ER stress transcriptional network apparently unaffected
in MDD or past month PTSD. Each of the genes tested are a transcriptional target of XBP1,
therefore the elevated expression observed in MDD may represent a change in ER stress
homeostasis.
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